Stockscreener 앱 받기
1.98
0.50%
-0.01
시간 외 거래:
1.98
Alx Oncology Holdings Inc 주식(ALXO)의 최신 뉴스
Is ALX Oncology Holdings (ALXO) outperforming other medical stocks this year? - MSN
ALXO Stock Price, Quote & Chart | ALX ONCOLOGY HOLDINGS INC (NASDAQ:ALXO) - ChartMill
Redmile Group, ALXO: Investment manager discloses 6.8% ownership - Stock Titan
HBM Healthcare (ALXO) discloses 8.59M shares, ~6.5% stake - Stock Titan
Earnings call transcript: ALX Oncology beats Q1 2026 earnings forecast - Investing.com
Q2 EPS Estimates for ALX Oncology Raised by HC Wainwright - MarketBeat
TradingKey - TradingKey
UBS Maintains ALX Oncology(ALXO.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year? - Yahoo Finance
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Q1 2026 Earnings Call Transcript - Insider Monkey
Alx Oncology Signals Promise, But Validation Looms - TipRanks
ALX Oncology outlines interim ASPEN-09 data from ~80 patients by mid-2027 as CD47-high cohort shows 22-month median PFS - MSN
H.C. Wainwright Maintains ALX Oncology(ALXO.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Piper Sandler Maintains ALX Oncology(ALXO.US) With Buy Rating, Maintains Target Price $4 - Moomoo
ALX ONCOLOGY ($ALXO) Releases Q4 2025 Earnings - Moomoo
ALX Oncology Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView
ALXO: ALX Oncology Reports Promising Data on CD47 Biomarker in H - GuruFocus
ALX Oncology Holdings Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
ALX ONCOLOGY ($ALXO) Releases Q1 2026 Earnings - Moomoo
ALX Oncology Holdings Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:ALXO) 2026-05-08 - Seeking Alpha
ALX Oncology Q1 Earnings Call Highlights - Barchart.com
Earnings call transcript: ALX Oncology Q1 2026 reveals clinical progress By Investing.com - Investing.com Canada
ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update - Investing News Network
ALX Oncology 1Q Loss/Shr 17c >ALXO - Moomoo
ALX Oncology Holdings Inc (NASDAQ:ALXO) Beats Q1 Estimates and Unveils Promising Breast Cancer Data - ChartMill
ALX Oncology Q1 2026 Earnings Call Transcript - MarketBeat
ALX Oncology Holdings 1Q 2026: Net income $(17.9M), EPS $(0.17) — 10-Q Summary - TradingView
[10-Q] ALX ONCOLOGY HOLDINGS INC Quarterly Earnings Report - Stock Titan
ALX Oncology reports Q1 net loss of $17.9M, cash $169.1M; advances evorpacept and ALX2004 programs - TradingView
ALXO: Durable clinical responses and reduced net loss highlight progress in HER2-positive cancer trials - TradingView
ALX Oncology Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
ALX Oncology (NASDAQ: ALXO) cuts Q1 loss, raises $150M for cancer pipeline - Stock Titan
ALX Oncology reports all 5 high-CD47 breast cancer patients responded - Stock Titan
ALX Oncology reports breast cancer trial data with CD47 biomarker - Investing.com UK
MSN Money - MSN
ALX Oncology's Evorpacept in Combination with Zanidatamab Generates Promising, Durable Response in Patients with Advanced HER2-Positive Breast Cancer and High CD47 Expression - Investing News Network
ALX Oncology reports breast cancer trial data with CD47 biomarker By Investing.com - Investing.com Australia
Insiders Buying ALX Oncology Holdings Might Wish They Invested More, Stock Gains 32% - Moomoo
Alx Oncology's evorpacept in combination with zanidatamab generates promising, durable response in patients with advanced her2-positive breast cancer and high cd47 expression - marketscreener.com
ALX Oncology’s Evorpacept in Combination with Zanidatamab Generates Promising, Durable Response in Patients with Advanced HER2-Positive Breast Cancer and High CD47 Expression - The Manila Times
In ALX breast cancer study, 5 of 5 high-CD47 patients responded - Stock Titan
ALX Oncology’s Evorpacept in Combination with Zanidatamab - GlobeNewswire
ALX Oncology Holdings Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
ALXO SEC FilingsAlx Oncology Holdings Inc 10-K, 10-Q, 8-K Forms - Stock Titan
ALX Oncology (ALXO.US) will release its earnings report before the market opens on May 8. - Moomoo
ALXO Stock Chart | ALX ONCOLOGY HOLDINGS INC (NASDAQ:ALXO) - ChartMill
Favourable Signals For ALX Oncology Holdings: Numerous Insiders Acquired Stock - Yahoo Finance
2.98%
1.33%
자본화:
|
볼륨(24시간):